Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation
Summary: Abundant donor cytotoxic T cells that attack normal host organs remain a major problem for patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Despite an increase in our knowledge of the pathobiology of acute graft versus host disease (aGvHD), the mechanisms regulat...
Main Authors: | Hemn Mohammadpour, Takemasa Tsuji, Cameron R. MacDonald, Joseph L. Sarow, Hanna Rosenheck, Saeed Daneshmandi, Jee Eun Choi, Jingxin Qiu, Junko Matsuzaki, Agnieszka K. Witkiewicz, Kristopher Attwood, Bruce R. Blazar, Kunle Odunsi, Elizabeth A. Repasky, Philip L. McCarthy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723002619 |
Similar Items
-
Established and Emerging Treatments of Skin GvHD
by: Cornelia S. Link-Rachner, et al.
Published: (2022-02-01) -
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
by: Mauro Di Ianni, et al.
Published: (2024-01-01) -
Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
by: Leuschner, U
Published: (2021) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
by: Kudakwashe Mhandire, et al.
Published: (2021-10-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
by: Martin eSzyska, et al.
Published: (2016-03-01)